First human test of OPT101 peptide begins
Knowledge-focused
Completed
This early-stage trial tested the safety of a new drug called OPT101 in 14 healthy volunteers. Participants received either OPT101 or a placebo, and researchers monitored for side effects, vital signs, and lab changes. The study was completed and focused only on safety and how th…
Phase: PHASE1 • Sponsor: Op-T LLC • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:23 UTC